KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Curent Deferred Tax Liability: 2012-2015

Historic Curent Deferred Tax Liability for Jazz Pharmaceuticals (JAZZ) over the last 3 years, with Sep 2015 value amounting to $9.4 million.

  • Jazz Pharmaceuticals' Curent Deferred Tax Liability rose 50.46% to $9.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $9.4 million, marking a year-over-year increase of 50.46%. This contributed to the annual value of $9.4 million for FY2014, which is 50.66% up from last year.
  • Jazz Pharmaceuticals' Curent Deferred Tax Liability amounted to $9.4 million in Q3 2015, which was down 0.22% from $9.4 million recorded in Q2 2015.
  • In the past 5 years, Jazz Pharmaceuticals' Curent Deferred Tax Liability registered a high of $9.4 million during Q2 2015, and its lowest value of $259,000 during Q1 2013.
  • For the 3-year period, Jazz Pharmaceuticals' Curent Deferred Tax Liability averaged around $5.8 million, with its median value being $6.3 million (2014).
  • Data for Jazz Pharmaceuticals' Curent Deferred Tax Liability shows a peak YoY surged of 2,316.60% (in 2014) over the last 5 years.
  • Jazz Pharmaceuticals' Curent Deferred Tax Liability (Quarterly) stood at $275,000 in 2012, then soared by 2,176.00% to $6.3 million in 2013, then soared by 50.66% to $9.4 million in 2014, then spiked by 50.46% to $9.4 million in 2015.
  • Its Curent Deferred Tax Liability was $9.4 million in Q3 2015, compared to $9.4 million in Q2 2015 and $9.4 million in Q1 2015.